Linkage of inflammatory bowel disease to human chromosome 6p.

Inflammatory bowel disease (IBD) is characterized by a chronic relapsing intestinal inflammation. IBD is subdivided into Crohn disease and ulcerative colitis phenotypes. Given the immunologic dysregulation in IBD, the human-leukocyte-antigen region on chromosome 6p is of significant interest. Previous association and linkage analysis has provided conflicting evidence as to the existence of an IBD-susceptibility locus in this region. Here we report on a two-stage linkage and association analysis of both a basic population of 353 affected sibling pairs (ASPs) and an extension of this population to 428 white ASPs of northern European extraction. Twenty-eight microsatellite markers on chromosome 6 were genotyped. A peak multipoint LOD score of 4.2 was observed, at D6S461, for the IBD phenotype. A transmission/disequilibrium test (TDT) result of P=.006 was detected for D6S426 in the basic population and was confirmed in the extended cohort (P=.004; 97 vs. 56 transmissions). The subphenotypes of Crohn disease, ulcerative colitis, and mixed IBD contributed equally to this linkage, suggesting a general role for the chromosome 6 locus in IBD. Analysis of five single-nucleotide polymorphisms in the TNFA and LTA genes did not reveal evidence for association of these important candidate genes with IBD. In summary, we provide firm linkage evidence for an IBD-susceptibility locus on chromosome 6p and demonstrate that TNFA and LTA are unlikely to be susceptibility loci for IBD.

[1]  T. Matise,et al.  Erratum: Automated construction of genetic linkage maps using an expert system (MultiMap): A human genome linkage map (Nature Genetics (1994) 6 (384- 390)) , 1994 .

[2]  R. Abramson,et al.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Russell,et al.  Transplantation antigens in Crohn's disease , 1975, The American journal of digestive diseases.

[4]  J. Partanen,et al.  Low Degree of DNA Polymorphism in the HLA‐Linked Lymphotoxin (Tumour Necrosis Factor β) Gene , 1988, Scandinavian journal of immunology.

[5]  D. Podolsky,et al.  Inflammatory bowel disease (1) , 1991, The New England journal of medicine.

[6]  N. Risch,et al.  A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus , 1998, Nature Genetics.

[7]  B. J. Dekker-Saeys,et al.  HISTOCOMPATIBILITY ANTIGENS AND OTHER GENETIC MARKERS IN ANKYLOSING SPONDYLITIS AND INFLAMMATORY BOWEL DISEASES , 1977, Journal of immunogenetics.

[8]  J. Terwilliger,et al.  Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 , 1996, Nature Genetics.

[9]  A. Andriulli,et al.  HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. , 1998, Italian journal of gastroenterology and hepatology.

[10]  L. Cardon,et al.  A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. , 1999, American journal of human genetics.

[11]  K. Livak,et al.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. , 1995, PCR methods and applications.

[12]  A. Peña,et al.  Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD) , 1996, Clinical and experimental immunology.

[13]  J. Satsangi,et al.  Genetic markers may predict disease behavior in patients with ulcerative colitis. , 1997, Gastroenterology.

[14]  E. Gazit,et al.  HLA antigens in ulcerative colitis and Crohn's disease in Israel. , 1980, Gastroenterology.

[15]  N. Dracopoli,et al.  Current protocols in human genetics , 1994 .

[16]  M. Gleeson,et al.  Human leucocyte antigens in Crohn's disease and ulcerative colitis , 1972, Gut.

[17]  A. Peña,et al.  Course and prognosis of Crohn's disease. , 1976, Gut.

[18]  S. Targan,et al.  A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease , 1997 .

[19]  S. Targan,et al.  Linkage of Crohn’s disease to the major histocompatibility complex region is detected by multiple non-parametric analyses , 1999, Gut.

[20]  H. Johansson,et al.  [Microangiographic studies in Crohn's disease and ulcerative colitis]. , 1971, Nordisk medicin.

[21]  W. Burnham,et al.  HLA-A and -B antigens in inflammatory bowel disease. , 1986, Gut.

[22]  J. Lennard-jones,et al.  Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.

[23]  J. Trent,et al.  Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Jewell,et al.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease , 1996, The Lancet.

[25]  C. Mathew,et al.  The interferon-Á gene as a positional and functional candidate gene for inflammatory bowel disease , 1998, International Journal of Colorectal Disease.

[26]  S. Targan,et al.  Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. , 1996, Gastroenterology.

[27]  R M Idury,et al.  A simple method for automated allele binning in microsatellite markers. , 1997, Genome research.

[28]  A. Peña,et al.  Genetic markers in clinically well defined patients with ulcerative colitis (UC) , 1999 .

[29]  J. Smolen,et al.  HLA antigens in inflammatory bowel disease , 1982 .

[30]  L Kruglyak,et al.  Limits on fine mapping of complex traits. , 1996, American journal of human genetics.

[31]  S. Schreiber,et al.  Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease , 2000, Immunogenetics.

[32]  Aravinda Chakravarti,et al.  Automated construction of genetic linkage maps using an expert system (MultiMap): a human genome linkage map , 1994, Nature Genetics.

[33]  B. Horsthemke,et al.  A NEW RESTRICTION FRAGMENT LENGTH POLYMORPHISM OF THE HUMAN TNF‐B GENE DETECTED BY Asp HI DIGEST , 1992, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[34]  J. Lanchbury,et al.  TNFB polymorphisms characterize three lineages of TNF region microsatellite haplotypes , 1997, Immunogenetics.

[35]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[36]  K. Isselbacher,et al.  An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  L. Cardon,et al.  Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. , 1998, Gastroenterology.

[38]  S. Targan,et al.  Distinct associations of HLA class II genes with inflammatory bowel disease. , 1993, Gastroenterology.

[39]  M. Newport,et al.  Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. , 1996, The Journal of infectious diseases.

[40]  N. Okabe,et al.  Immunological studies in Crohn's disease. I. Association with HLA systems in the Japanese. , 1984, Journal of clinical & laboratory immunology.

[41]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.

[42]  James T. Elder,et al.  Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. , 1997, Human molecular genetics.

[43]  Jeff Hall,et al.  Automated Fluorescent Genotyping , 1997, Current protocols in human genetics.

[44]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Terwilliger.  A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. , 1995, American journal of human genetics.

[46]  J. Hugot,et al.  Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D. , 1994, American journal of medical genetics.

[47]  L. Abraham,et al.  The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .

[48]  J. Lennard-jones,et al.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). , 1996, Gut.

[49]  Olive Lloyd-Baker.  IDENTIFICATION OF NOVEL , 1964 .

[50]  U. Spengler,et al.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production , 1991, The Journal of experimental medicine.

[51]  T. Kodama,et al.  HLA-linked susceptibility and resistance genes in Crohn's disease. , 1995, Gastroenterology.

[52]  J. Hampe,et al.  Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease , 1999, The Lancet.

[53]  J. Weber,et al.  Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  E. Lander,et al.  Complete multipoint sib-pair analysis of qualitative and quantitative traits. , 1995, American journal of human genetics.